Retrophin Inc (NASDAQ:RTRX)

12.55
Delayed Data
As of Sep 20
 +0.17 / +1.37%
Today’s Change
11.39
Today|||52-Week Range
29.70
-44.54%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close12.38
Today’s open12.39
Day’s range12.28 - 12.66
Volume1,621,818
Average volume (3 months)609,123
Market cap$523.2M
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-64.90%
Earnings growth (this year)-129.23%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+6.01%
P/E ratioNM
Price/Sales5.57
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
MORFMorphic Holding Inc+0.31+1.78%
MYOVMyovant Sciences Ltd-0.06-0.99%
DTILPrecision BioScience...-0.39-3.88%
PSNLPersonalis Inc+0.26+1.61%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$164.2M
Annual profit (last year)-$102.7M
Net profit margin-62.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Eric Dube
Chief Financial &
Accounting Officer
Laura M. Clague
Corporate headquarters
San Diego, California

Forecasts